Legend Capital and IDG have led a USD 42 million Series A investment in BCIFlex, a China-based company focusing on brain-computer interface technology.

Information on the Target

BCIFlex is an innovative company based in China, specializing in brain-computer interface (BCI) systems. The company aims to enhance human-computer interaction through advanced technology that seamlessly translates neural signals into actionable data, thus paving the way for new applications in various fields, including healthcare, gaming, and accessibility.

BCIFlex's cutting-edge technology holds the promise to revolutionize industries by enabling direct communication between the human brain and external devices, fostering advancements in neuroprosthetics, cognitive enhancement, and rehabilitation solutions.

Industry Overview

The brain-computer interface industry has seen substantial growth in China, driven by increasing investments in technology and healthcare innovation. With the risin